CHARGED ALPHATMFrontier AI stock research

ANGO · NasdaqGS

AngioDynamics, Inc.

Medical Instruments & Supplies · United States

USD 15.440.5% daily changeQuote 2026-09-18 · USD
Market cap (USD)
US$638.17M
Trailing P/E
Forward P/E
Quarterly revenue growth
8.0%
Trailing net margin
-11.5%
Indicated dividend yield

Snapshot 2026-09-20 · Latest financial period 2026-05-31 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-01 (provider estimate, not issuer-confirmed).

Company background

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Company website

Q4 FY2026

Go beyond the headline.

Comparable businesses

ANGO peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricANGOAngioDynamics, Inc.Snapshot 2026-09-20Financial period: 2026-05-31KMTSKestra Medical Technologies, Ltd.Snapshot 2026-09-20Financial period: 2026-07-31MMEDMiniMed Group, Inc.Snapshot 2026-09-20Financial period: 2026-07-31
Market capMarket value, converted to USDUS$638.17MUS$1.46BUS$6.13B
Forward P/EProvider forward earnings estimate34.14x
EV / EBITDAEnterprise value / trailing EBITDA3,166.30x20.92x
Revenue growthLatest quarter vs prior-year quarter8.0%59.9%16.6%
Operating marginLatest reported quarter-6.5%-121.6%0.5%
Free cash flow yieldTrailing cash flow / market cap3.4%-5.0%
Net debt / EBITDANet debt / trailing EBITDA-228.23x-0.52x
Debt / equityTotal debt / positive book equity0.06x0.34x0.02x
Trailing P/ETrailing twelve-month earnings
Price / bookPrice / positive book equity per share3.77x6.51x1.69x
EV / salesEnterprise value / trailing revenue1.86x12.49x1.86x
Earnings growthLatest quarter vs prior-year quarter
Gross marginTrailing twelve months54.6%53.9%56.9%
Net marginTrailing twelve months-11.5%-140.4%-9.7%
Return on equityProvider trailing return; positive equity only-20.8%-73.7%-8.7%
Free cash flow marginTrailing free cash flow / revenue6.8%-67.5%
Dividend yieldIndicated annual dividend / price
Earnings payoutProvider trailing dividend payout0.0%0.0%0.0%
Current ratioCurrent assets / current liabilities2.19x4.69x1.81x
BetaProvider historical market sensitivity0.33

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-20. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for ANGO

All available reporting periods
Q4 FY20262026-07-15

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.